3.9 Article

Phosphorylation of irs1 at SER-522 inhibits insulin signaling

Journal

MOLECULAR ENDOCRINOLOGY
Volume 21, Issue 9, Pages 2294-2302

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1210/me.2007-0159

Keywords

-

Funding

  1. NIDDK NIH HHS [DK038712, DK067818] Funding Source: Medline

Ask authors/readers for more resources

Multisite phosphorylation of Irs1 on serine and threonine residues regulates insulin signaling that can contribute to insulin resistance. We identified by mass spectrometry the phosphorylation of Ser522 in rat Irs1 ( S522(Irs1)). The functional effects of this phosphorylation site were investigated in cultured cells using a sequencespecific phosphoserine antibody. Insulin stimulated the phosphorylation of S522(Irs1) in L6 myoblasts and myotubes. S522(Irs1) phosphorylation was inhibited by wortmannin, whereas PD98059, rapamycin, or glucose-starvation had no effect. Reducing Akt expression with small interfering RNA inhibited insulin-stimulated phosphorylation of S522(Irs1), suggesting the involvement of the phosphatidylinositol 3-kinase3 -> Akt cascade. A S522(Irs1)-> A522(Irs1) substitution increased insulinstimulated tyrosine phosphorylation of Irs1 and signaling, whereas a S522(Irs1)-> E522(Irs1) substitution reduced insulin-stimulated Irs1 tyrosine phosphorylation. Together, these results suggest the phosphatidylinositol 3-kinase -> Akt cascade can inhibit insulin signaling through the phosphorylation of S522(Irs1).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available